Lanka Ventures invests in vascular health assessment specialists Jendo Innovations

Lanka Ventures Chairman Damith Pallewatte (left) exchanging the investment agreement with Jendo Innovations Co-founder and CEO Keerthi Kodithuwakku. Lanka Ventures CEO Palitha Gamage is also present

In a ground-breaking development, Lanka Ventures, has announced a strategic investment in Jendo Innovations, a cutting-edge biomedical engineering startup based in Sri Lanka.

Jendo Innovations has pioneered a revolutionary medical device designed to advance the early diagnosis of vascular diseases, and this significant investment is poised to propel their innovation into the global healthcare market. Jendo Innovations’ ground-breaking product, the Jendo device, has garnered widespread attention for its ability to analyse endothelial function, a critical indicator in the early stages of numerous cardiovascular diseases. By harnessing the power of non-invasive techniques such as Photoplethysmography (PPG) and Digital Thermal Monitoring (DTM), the Jendo device ensures a comfortable and seamless experience for patients while delivering highly accurate results.

The device’s cloud-based artificial intelligence system further amplifies its capabilities by efficiently processing and analysing data. This makes it an invaluable tool for diagnosing conditions like atherosclerosis, nephropathy, neuropathy, and varicose veins, transforming the landscape of vascular health assessment. What sets Jendo Innovations apart is its pioneering diagnostics methods for vascular assessment, which has undergone extensive clinical testing and received patents in key markets such as the United States, Japan, and Sri Lanka. These patents underscore the device’s uniqueness and its immense potential to revolutionise vascular health assessment globally. Lanka Ventures, with major shareholders including Hatton National Bank and DFCC Bank, has primarily focused its investments in the energy and health sectors. Their decision to invest in Jendo Innovations reflects the firm’s commitment to supporting ground-breaking innovations in healthcare technology.

Lanka Ventures Chairman Damith Pallewatte said, “We are excited to be a part of Jendo Innovations’ journey. Their ground-breaking technology has the potential to make a significant impact on global healthcare by enabling early diagnosis of vascular diseases. We believe in their vision and are confident that this investment will help bring their innovation to market faster.”

Jendo Innovations Co-founder and CEO Keerthi Kodithuwakku said, “We are thrilled to have Lanka Ventures as our partner. This investment will accelerate our plans to move from the prototype stage to production. We also aim to secure regulatory approvals in Sri Lanka, Japan, and the USA, bringing our ground-breaking technology to patients worldwide.” The investment from Lanka Ventures represents a pivotal moment for Jendo Innovations as they prepare to take their pioneering vascular health assessment technology to the global stage. With the support of this strategic partnership, the Jendo device is poised to become an indispensable tool in the early detection and management of vascular diseases, potentially saving countless lives in the process.